Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 2,856 | 2,532 | 954 | 889 | 2,776 |
| Gross Profit | 2,856 | 2,532 | 954 | 889 | 2,776 |
| Operating Expenses | 22,260 | 21,333 | 20,755 | 19,447 | 19,883 |
| Operating Income | -19,404 | -18,801 | -19,801 | -18,558 | -17,107 |
| Interest Expense | 1,779 | 1,778 | 914 | 745 | 532 |
| Other Income | -6 | -1 | 5 | 16 | -7 |
| Pre-tax Income | -21,189 | -20,580 | -20,710 | -19,287 | -17,646 |
| Income Tax | N/A | N/A | N/A | 2 | N/A |
| Net Income Continuous | -21,189 | -20,580 | -20,710 | -19,289 | -17,649 |
| Net Income | $-21,189 | $-20,580 | $-20,710 | $-19,289 | $-17,649 |
| EPS Basic Total Ops | -0.55 | -0.54 | -0.55 | -0.51 | -0.14 |
| EPS Basic Continuous Ops | -0.55 | -0.54 | -0.55 | -0.51 | -0.16 |
| EPS Diluted Total Ops | -0.55 | -0.54 | -0.55 | -0.51 | -0.14 |
| EPS Diluted Continuous Ops | -0.55 | -0.54 | -0.55 | -0.51 | -0.16 |
| EBITDA(a) | $-18,696 | $-18,103 | $-19,270 | $-18,066 | $-16,699 |